🕵️ Context Therapeutics Inc. ($CNTX)
SEC insider & ownership activity, last 12 months · CIK 1842952 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. MPM Bioimpact LLC trimmed 16.4% → 11.6%; Blue OWL Capital Holdings LP trimmed 8.5% → 5.5%. One red-flag 8-K in the window: Delisting notice (3.01), Aug 28, 2025.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| MPM Bioimpact LLC | 11.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Avidity Partners Management LP | 8.7% | 13G | May 12, 2026 | filing ↗ | |
| Avidity Partners Management (GP) LLC | 8.7% | 13G | May 12, 2026 | filing ↗ | |
| Avidity Capital Partners Fund (GP) LP | 8.7% | 13G | May 12, 2026 | filing ↗ | |
| Avidity Capital Partners (GP) LLC | 8.7% | 13G | May 12, 2026 | filing ↗ | |
| Michael Gregory | 8.7% | 13G | May 12, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 8.3% | 13G | May 15, 2025 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 8.3% | 13G | May 15, 2025 | filing ↗ | |
| David Kroin | 8.3% | 13G | May 15, 2025 | filing ↗ | |
| Avidity Private Master Fund I LP | 7.7% | 13G | May 12, 2026 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Soleus Capital, LLC | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Soleus Capital Group, LLC | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Soleus Capital Management, L.P. | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Soleus GP, LLC | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Guy Levy | 7.6% | 13G | May 8, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.7% | 13G | Jul 27, 2026 | filing ↗ | |
| Octagon Capital Advisors LP | 5.7% | 13G | May 14, 2026 | filing ↗ | |
| Octagon Investments Master Fund LP | 5.7% | 13G | May 14, 2026 | filing ↗ | |
| Ting Jia | 5.7% | 13G | May 14, 2026 | filing ↗ | |
| Blue OWL Capital Holdings LP | 5.5% | 13G | May 14, 2026 | filing ↗ | |
| Franklin Advisers, Inc. | 5.3% | 13G | Jan 27, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Charter/bylaw changes (5.03) | Jun 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 15, 2026 | filing ↗ |
| Other events (8.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Material agreement (1.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 2, 2026 | filing ↗ |
| Other events (8.01) | Apr 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 24, 2025 | filing ↗ |
| Other events (8.01) | Oct 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 24, 2025 | filing ↗ |
| Other events (8.01) | Oct 17, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 28, 2025 | filing ↗ |